A Pivotal Moment in Global Lung Cancer Detection
This October marks a significant milestone in the global fight against lung cancer. Coreline Soft is bringing together leading voices from two continents to examine how artificial intelligence is fundamentally reshaping national approaches to lung cancer screening. Through back-to-back international webinars on October 14-15, healthcare professionals worldwide will explore real-world implementations, clinical insights, and the future trajectory of AI-assisted early detection programs.
Lung cancer remains one of the most lethal cancers globally, yet early detection dramatically improves survival rates. As countries worldwide recognize the urgent need for systematic screening programs, AI technology has emerged as a critical enabler—helping healthcare systems manage scale, improve accuracy, and optimize resource allocation.
Australia: Architecting a National Screening Framework
Australia stands at the forefront of establishing a comprehensive national lung cancer screening program. This webinar brings together experts from Lungscreen Australia and Coreline Soft to explore the strategic, clinical, and technological dimensions of building screening infrastructure at scale.
- Program Agenda:
- Session 1: Building a National Model for Lung Cancer Screening in Australia (20 min)
Dr. Siavash Es'haghi, CEO and Managing Director of Lungscreen
- Session 2: How Coreline's AI Can Help Radiologists in Lung Cancer Screening Programs (20 min)
Dr. Jaeyoun Yi, CTO & Co-founder, Coreline Soft
This 60-minute session offers a comprehensive look at how Australia is approaching population-level screening—from national strategy to AI-powered radiologist support.
Italy: Clinical Realities and Future Horizons
"Screening del Cancro Polmonare con l'Intelligenza Artificiale – Pratica Clinica e Prospettive in Italia"
Italy brings a rich tradition of clinical excellence and research innovation to lung cancer screening. This Italian-language webinar features leading voices from Italy's academic medical centers discussing current clinical practice and future perspectives on AI-assisted screening.
- Moderator: Professor Nicola Sverzellati
Professor of Radiology & Director of Diagnostic Department, University Hospital of Parma
- Speaker #1: Professor Stefano Palmucci - "LCS ora in Italia" (Lung Cancer Screening Now in Italy)
Department of Medical Surgical Sciences and Advanced Technologies, University of Catania
Pulmonary Imaging and Advanced Radiological Technologies Unit (IPTRA), University Hospital Policlinico G. Rodolico-San Marco, Catania
- Speaker #2: Professor Mario Silva - "Pratica Clinica: Noduli Polmonari" (Clinical Practice: Pulmonary Nodules)
MD, PhD, Radiologist, Department of Medicine and Surgery, University Hospital of Parma
This 60-minute session (50 minutes + Q&A) will be conducted in Italian, providing deep clinical insights into pulmonary nodule management and the current state of lung cancer screening in Italy.
AI as a Global Imperative in Lung Cancer Screening
These consecutive webinars illuminate a fundamental shift occurring across international healthcare systems: lung cancer screening is transitioning from pilot programs to national imperatives—and AI is playing an indispensable role in making this scale possible.
The Global Context:
- Rising Demand: As populations age and screening guidelines expand, healthcare systems face unprecedented volumes of CT scans requiring expert interpretation.
- Resource Constraints: Many regions experience shortages of specialized radiologists, making AI-assisted triage and detection increasingly valuable.
- Standardization Needs: National programs require consistent interpretation standards across multiple sites and practitioners—an area where AI can provide valuable support.
- Evidence Base: Accumulating research demonstrates that AI tools can assist in detecting small nodules, reducing reading time, and supporting consistent follow-up recommendations.
What Makes This Moment Unique:
The convergence of these two webinars—one focused on national infrastructure, the other on clinical integration—reflects how countries at different stages of implementation are learning from each other. Australia's systems-level approach and Italy's clinical depth represent complementary perspectives on the same challenge: how to save lives through earlier lung cancer detection.
From Melbourne to Milan, healthcare professionals are grappling with similar questions: How do we manage screening volumes? How do we ensure quality and consistency? How do we integrate new technologies while maintaining clinical rigor? These webinars provide a rare opportunity to hear directly from those shaping the answers.
Join the Global Conversation
Whether you're a radiologist evaluating AI tools, a program administrator designing screening initiatives, or a healthcare leader considering national implementation, these webinars offer actionable insights from real-world experience.
This is more than a discussion about technology—it's about the future of preventive healthcare and our collective ability to detect cancer when treatment is most effective.
Space is limited. Reserve your spot today to be part of this global dialogue on AI-powered lung cancer screening.
About the Webinar Series: These educational webinars are designed for healthcare professionals interested in lung cancer screening, AI technology in radiology, and national healthcare program development. The
Australia webinar will be conducted in English, and the
Italy webinar will be conducted in Italian. Both sessions include opportunities for Q&A with expert presenters.
List
